More Investing
View Older Stories View Newer Stories-
Stellantis shares slide lower on soft H2 results, loose guidance
-
Lucid shares jump on strong 2025 vehicle production outlook; CEO steps down
-
Auto1 Group shares spike on better-than-anticipated fourth-quarter earnings
-
AstraZeneca breast cancer drug shows positive results, shares up
-
GM approves new share buyback, dividend increase
-
Boeing (BA) announces executive changes, board reduction
-
Supermicro stock surges after filing delayed reports
-
US oil futures climb slightly after API reports surprise draw in crude stockpiles
-
Cava Group posts surprise profit, beats revenue estimates but shares slump
-
Intuit fiscal Q2 results top estimates, reiterates FY guidance; lifts dividend
-
First Solar shares down as Q4 profit miss, issues 2025 guidance below expectations
-
Teva (TEVA) and Medincell Announce FDA Acceptance of sNDA for UZEDY Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder
-
Workday stock soars 8% on earnings beat, strong guidance
-
Live Nation (LYV) stock drops amid FTC breakup comments
-
Porsche announces executive board reshuffle
-
Maze Therapeutics receives positive ratings following recent IPO
-
Warner Bros. Discovery (WBD) shuts down three game studios, halts Wonder Woman game - Bloomberg
-
Snowflake target raised at Canaccord ahead of earnings
-
Wall Street bullish on Metsera following January IPO on obesity drug pipeline
-
Bank of America’s preview of 3M investor day
-
Wall Street analysts upbeat on CyberArk’s investor day targets
-
Morgan Stanley sees FDA approval of GILD's Lenacapavir
-
Argus cuts Domino’s rating to hold on cost pressures, weak U.S. sales
-
Morgan Stanley bullish on Progressive, lifts EPS estimate
-
JP Morgan cuts Tempus AI rating to ‘neutral’ after stock’s sharp rally
-
Lilly unveils higher vial doses of obesity drug that are cheaper than injector pen
-
Block valuation now 'reflective of risks': Morgan Stanley
-
CDPQ to buy renewable power company Innergex in $10 billion deal
-
Paypal shares up after earnings outlook
-
Donut chain Krispy Kreme unveils disappointing guidance, sending shares tumbling
-
Novo shares rise as HIMS halt sales of some obesity drugs
-
Unilever shares down on CEO Hein Schumacher's exit
-
European markets mixed as Germany's economy contracts; Unilever CEO steps down
-
Crypto stock including MicroStrategy, Coinbase, Riot fall after BTC below $90k
-
Alibaba, US-listed Chinese stocks rebound after sharp Monday sell-off
-
Cleveland-Cliffs shares down on wider-than-expected loss
-
Zoom beats Q4 profit estimates, but shares down 3% on dour guidance
-
Hims&Hers Health Q4 earnings fall short of estimates
-
TD Cowen raises Mondelez price target, EPS estimate on falling Cocoa cost
-
BofA upgrades CF Industries on improved nitrogen market, risk/reward
-
Guggenheim upgrades Wingstop on growth potential, shares up
-
Supermicro stock falls ahead of critical financial update
-
RTX rated buy at UBS on international defense, margin improvement
-
DoorDash (DASH) to pay $16.75 million settlement over deceptive pay practices
-
UBS upgrades TransDigm on margin expansion, capital deployment
-
US Treasury sells $69 of 2YR notes at lower-than-expected yield
-
Lucid stock dips after Redburn-Atlantic slashes price target
-
Smithfield Foods returns to U.S. market with Buy ratings from brokerages
-
BofA cuts rating, target on Rivian due to mounting risks
-
Western Digital completes SanDisk spin-off
